APTX — Apotex Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$7.15bn
- CA$9.91bn
- CA$3.49bn
Annual cashflow statement for Apotex Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -147 | 152 | 374 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 415 | 585 | 403 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 152 | -318 | -286 |
| Net Change in Other Assets & Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 571 | 554 | 641 |
| Capital Expenditures | -83.3 | -93.6 | -121 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -2,614 | -534 | -56 |
| Acquisition of Business | |||
| Sale of Fixed Assets | |||
| Change in Net Intangibles | |||
| Cash from Investing Activities | -2,697 | -628 | -177 |
| Financing Cash Flow Items | -12.1 | 0 | -14.9 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -282 | -279 | -483 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -2,405 | -343 | -21 |